Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Bone|September 15, 2006
CYP17 and COMT gene polymorphisms can influence bone directly, or indirectly through their effects on endogenous sex steroids, in postmenopausal Japanese womenItsuo Gorai, Mae Inada, Hiroko Morinaga, et al.Cancer Letters|March 16, 2005
Analysis of gene expression induced by diethylstilbestrol (DES) in human primitive Mullerian duct cells using microarrayYasuhiro Miki, Takashi Suzuki, Chika Tazawa, et al.The Journal of Clinical Endocrinology and Metabolism|February 8, 2003
Estrogen-metabolizing gene polymorphisms, but not estrogen receptor-alpha gene polymorphisms, are associated with the onset of menarche in healthy postmenopausal Japanese womenItsuo Gorai, Kumiko Tanaka, Mae Inada, et al.Journal of Bone and Mineral Metabolism|October 15, 2009
Validation of the Japanese Osteoporosis Quality of Life QuestionnaireKeigo Kumamoto, Toshitaka Nakamura, Takao Suzuki, et al.Journal of Bone and Mineral Metabolism|April 5, 2013
Diagnostic criteria for primary osteoporosis: year 2012 revisionSatoshi Soen, Masao Fukunaga, Toshitsugu Sugimoto, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 15, 2010
Effects of bazedoxifene on bone mineral density, bone turnover, and safety in postmenopausal Japanese women with osteoporosisAkira Itabashi, Kousei Yoh, Arkadi A Chines, et al.Journal of Bone and Mineral Metabolism|April 10, 2014
Bridging analysis of the efficacy and safety of bazedoxifene in Japanese and global populations of postmenopausal women with osteoporosisAkira Itabashi, Kousei Yoh, Arkadi A Chines, et al.Journal of Bone and Mineral Metabolism|December 22, 2005
Randomized trial comparing low-dose hormone replacement therapy and HRT plus 1alpha-OH-vitamin D3 (alfacalcidol) for treatment of postmenopausal bone lossHideki Mizunuma, Masataka Shiraki, Masafumi Shintani, et al.Journal of Bone and Mineral Metabolism|August 4, 2016
Comparison of concurrent treatment with vitamin K<sub>2</sub> and risedronate compared with treatment with risedronate alone in patients with osteoporosis: Japanese Osteoporosis Intervention Trial-03Shiro Tanaka, Teruhiko Miyazaki, Yukari Uemura, et al.The Journal of Clinical Endocrinology and Metabolism|March 21, 2014
Clinical Trials Express: fracture risk reduction with denosumab in Japanese postmenopausal women and men with osteoporosis: denosumab fracture intervention randomized placebo controlled trial (DIRECT)Toshitaka Nakamura, Toshio Matsumoto, Toshitsugu Sugimoto, et al.Pageof 3